JUL 16, 2019 3:18 AM PDT

Rare Bone Marrow Manifestation in Sarcoidosis

WRITTEN BY: Dena Aruta

Sarcoidosis is an inflammatory disease with the hallmark diagnostic feature being non-caseating granulomas--clumps of immune cells including macrophages, epithelial cells, and histiocytes. While 90% of people diagnosed with sarcoidosis have it in their lungs, the disease can affect any organ system in the body. Common extrapulmonary sites include skin, liver, eyes, and lymph nodes. The incidence in the U.S. is approximately is 10 per 100,000 people. The principal investigator, J. Isaac Peña-Garcia, and colleagues, discuss a case study involving a rare manifestation of sarcoidosis in the bone marrow. 

Bone marrow sarcoidosis (BMS) has not been described frequently in the literature. Peña-Garcia cites several studies that illustrate the wide variation in age, gender, and ethnicity, which is common in the involvement of other extrathoracic organs. In a prospective cohort study in which the participants were 95.8% Caucasian, 640 patients were followed over 40 years. None had bone marrow manifestations initially, and at follow up, only 0.3% had BMS. In contrast, in the  ACCESS (A Case-Control Etiologic Study of Sarcoidosis) study, there were 640 patients, of which 44% were African Americans, and 3.9% had BMS. 

In this case study, Peña-Garcia describes a 51-year-old African American woman with a previous diagnosis of cutaneous sarcoidosis. She presented with bilateral knee and lower leg pain as well as paresthesias without neurological involvement. She also had a "low-grade fever, hyporexia with an unintentional 30-pound weight loss over two years, and chronic dry cough." Among the numerous tests performed, a peripheral blood smear showed leukocytopenia and decreased red blood cells. The bone marrow biopsy showed normal cell lineage and non-caseating granulomas consistent with sarcoidosis.

The authors created an algorithm to follow when sarcoidosis patients present with decreased white blood cells and anemia:

Figure 1. A proposed approach to patient with sarcoidosis presenting with cytopenias. Credit  Peña-Garcia et al.

There have been no RCTs that compare different treatments, and to date, no FDA-approved treatment strategies for BMS, but prednisone is the gold standard for treatment of other forms of sarcoidosis. Methotrexate, which is used as a steroid-sparing medication, cannot be used in BMS due to its cytotoxic properties.

 

About the Author
  • After earning my Bachelor of Science degree in biology/chemistry from Virginia Polytechnic Institute and State University (aka Va. Tech), I went on to complete clinical rotations in laboratory medicine at Roanoke Memorial Hospital. I spent the next 21 years working in healthcare as a clinical microbiologist. In 2015, I combined my fascination with medicine and passion for writing into a freelance career, and I haven't looked back. Even though my expertise is in microbiology and infectious diseases, I'm adept at writing about any medical topic. Being a freelance writer allows me to pursue a career where I can work at home with my two feline assistants, Luke and Grace. I'm a firm supporter of animal rights and volunteer for a local rescue during my free time. 
You May Also Like
MAR 05, 2020
Health & Medicine
MAR 05, 2020
Colorectal Cancers on the Rise in Younger People
Colorectal cancer rates are rising among young Americans, according to the most recent report from the American Cancer Society (ACS). Every three years, th...
MAR 04, 2020
Technology
MAR 04, 2020
Artificial Intelligence Could Improve Sleep Care
Artificial intelligence (AI) has long been used for applications in healthcare and now it holds the potential to improve efficiencies and precision in slee...
MAR 15, 2020
Microbiology
MAR 15, 2020
COVID-19 - What To Do If You Get Sick
It now seems that the SARS-CoV-2 virus is spreading through communities in many places worldwide....
MAR 20, 2020
Neuroscience
MAR 20, 2020
The Little Things Matter: The Mental Impact of Social Distancing
Image: Metropolitian State University of Denver The COVID-19 pandemic has caused social interactions, resources, and most aspects of daily life to halt ind...
MAR 20, 2020
Technology
MAR 20, 2020
Control Release Technology for Medically Favorable Gases
Researchers have recently developed solid material that can control the release of physiologically favorable gases. The study is critical in administering ...
MAR 26, 2020
Microbiology
MAR 26, 2020
US Now Leads the World in Coronavirus Cases
In the United States, there have been 83,836 confirmed cases of COVID-19, and over 529,000 worldwide....
Loading Comments...